Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Sees Significant Increase in Short Interest

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) saw a large growth in short interest in September. As of September 15th, there was short interest totalling 4,200 shares, a growth of 50.0% from the August 31st total of 2,800 shares. Based on an average daily volume of 30,300 shares, the short-interest ratio is currently 0.1 days.

Invesco Nasdaq Biotechnology ETF Stock Performance

IBBQ stock traded up $0.06 during trading on Friday, reaching $23.70. The company had a trading volume of 3,700 shares, compared to its average volume of 21,242. The firm has a 50-day simple moving average of $24.01 and a 200-day simple moving average of $22.77. The company has a market cap of $35.31 million, a price-to-earnings ratio of 17.39 and a beta of 0.61. Invesco Nasdaq Biotechnology ETF has a twelve month low of $18.18 and a twelve month high of $24.84.

Invesco Nasdaq Biotechnology ETF Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 27th. Investors of record on Monday, September 23rd will be paid a $0.089 dividend. The ex-dividend date is Monday, September 23rd. This is a boost from Invesco Nasdaq Biotechnology ETF’s previous quarterly dividend of $0.05. This represents a $0.36 dividend on an annualized basis and a yield of 1.50%.

Institutional Trading of Invesco Nasdaq Biotechnology ETF

A hedge fund recently bought a new stake in Invesco Nasdaq Biotechnology ETF stock. Lake Street Advisors Group LLC bought a new position in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) in the first quarter, according to its most recent filing with the SEC. The firm bought 12,917 shares of the company’s stock, valued at approximately $286,000. Lake Street Advisors Group LLC owned approximately 0.88% of Invesco Nasdaq Biotechnology ETF as of its most recent SEC filing.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.